Institute of Oncology Research (IOR) at ENA 2026
Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website
Institute of Oncology Research (IOR) brings 7 presentations to ENA 2026 in Barcelona. Its posters centre on lymphoma, especially marginal zone lymphoma, and on ways to strengthen BTK-targeted therapy or overcome resistance to it. Agents tested include the CBP/EP300 inhibitor TT125-802, orelabrutinib with mesutoclax, and FF01, an antibody against a human endogenous retrovirus envelope.
| Organization | ENA 2026 Attendance |
|---|---|
Institute of Oncology Research (IOR) Bellinzona, Switzerland | |
Cancer research institute affiliated with Università della Svizzera italiana, with programmes including lymphoma and prostate cancer. | Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm |
Instantly find 20 buyers from Institute of Oncology Research (IOR)
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction